Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418477
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-13
Brief Title:
Daratumumab Bortezomib Cyclophosphamide and Dexamethasone Therapy for Patients with MIDD
Sponsor:
Organization:
Peking University Peoples Hospital